They also showed that suppressing MUC1 enhanced EREG production in fibroblasts and lung cancer cells, whereas treatment with recombinant human EREG protected lung cancer cells from MUC1 inhibitor-induced cell death [42]. Here, EREG is linked to lung carcinoma.